insights_auto
Por que ALMKT caiu 2,74%?
Saiba maischevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ 0,092
arrow_downward
-2,74%(-0,0026) 1D
12 de nov., 17:35:12 GMT+1 · EUR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para ALMKT…
Abrir
€ 0,10
Alta
€ 0,10
Baixa
€ 0,09
Valor de mercado
19,00 mi
Volume médio
545,11 mil
Volume
189,93 mil
Índice P/L
0,79
Alto — 52 sem
€ 0,23
Baixo — 52 sem
€ 0,07
LPA
€ 0,12
Ações em circulação
195,26 mi
Nº de funcionários
56
Abrir
€ 0,10
Alta
€ 0,10
Baixa
€ 0,09
Valor de mercado
19,00 mi
Volume médio
545,11 mil
Volume
189,93 mil
Índice P/L
0,79
Alto — 52 sem
€ 0,23
Baixo — 52 sem
€ 0,07
LPA
€ 0,12
Ações em circulação
195,26 mi
Nº de funcionários
56
Notícias
De fontes da web e parceiros de notícias
TradingView
·
há 1 hora
S&P 500 and Nasdaq Recover From Early Losses -- AI Fears Still Hang Over Tech Stocks
24/7 Wall St.
·
há 1 hora
America's Biggest Bank Turned $1,000 Into $5,559 in Ten Years, Beating the S&P 500 by $1,519
ChartMill
·
há 1 hora
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
The Motley Fool
·
há 2 horas
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Perfil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Sobre Mauna Kea Technologies SA